MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression

Sook Jin Jang, In Sun Choi, Geon Park, Dae Soo Moon, Ji Seon Choi, Myung-Hyun Nam, Soo-Young Yoon, Cheol Hee Choi, Seong Ho Kang

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Micro (mi)RNA dysregulation is implicated in the development of myelodysplastic syndrome (MDS). Chromosomal abnormalities on 1q are frequently detected in Korean patients with MDS; however, how these are related to disease development is unknown. The present study compared the expression profiles of miRNAs encoded by chromosome 1q between 65 MDS patients and 11 controls. We found that miR-205-5p levels were 12.5 fold higher in the former (P = 0.001). miR-205-5p level was increased in 44.7% of patients when an arbitrary 2−ΔCt cut-off value of 1.25 was used. miR-205-5p expression data were used to generate a receiver operating characteristic (ROC) curve for miR-205-5p, for which the area under the curve (AUC) was 0.825 (95% confidence interval: 0.710–0.941; P = 0.001). Moreover, transfection with a miR-205-5p mimic induced cell proliferation by inhibiting the expression of the tumor suppressor protein phosphatase and tensin homolog (PTEN). Our findings suggest that miR-205-5p upregulation contributes to MDS by suppressing PTEN and that miR-205-5p thus acts as an oncogene in hematopoietic cells.

Original languageEnglish
Pages (from-to)172-177
Number of pages6
JournalLeukemia Research
Volume47
DOIs
Publication statusPublished - 2016 Aug 1

Fingerprint

Myelodysplastic Syndromes
MicroRNAs
Phosphoric Monoester Hydrolases
Cell Proliferation
Tumor Suppressor Proteins
Phosphoprotein Phosphatases
Oncogenes
ROC Curve
Chromosome Aberrations
Area Under Curve
Transfection
Up-Regulation
Chromosomes
Confidence Intervals
Tensins

Keywords

  • Diagnosis
  • MDS
  • miR-205-5p
  • Oncogene
  • Upregulation

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression. / Jang, Sook Jin; Choi, In Sun; Park, Geon; Moon, Dae Soo; Choi, Ji Seon; Nam, Myung-Hyun; Yoon, Soo-Young; Choi, Cheol Hee; Kang, Seong Ho.

In: Leukemia Research, Vol. 47, 01.08.2016, p. 172-177.

Research output: Contribution to journalArticle

Jang, Sook Jin ; Choi, In Sun ; Park, Geon ; Moon, Dae Soo ; Choi, Ji Seon ; Nam, Myung-Hyun ; Yoon, Soo-Young ; Choi, Cheol Hee ; Kang, Seong Ho. / MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression. In: Leukemia Research. 2016 ; Vol. 47. pp. 172-177.
@article{e4daa9065aa448c8a0c454415daa7835,
title = "MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression",
abstract = "Micro (mi)RNA dysregulation is implicated in the development of myelodysplastic syndrome (MDS). Chromosomal abnormalities on 1q are frequently detected in Korean patients with MDS; however, how these are related to disease development is unknown. The present study compared the expression profiles of miRNAs encoded by chromosome 1q between 65 MDS patients and 11 controls. We found that miR-205-5p levels were 12.5 fold higher in the former (P = 0.001). miR-205-5p level was increased in 44.7{\%} of patients when an arbitrary 2−ΔCt cut-off value of 1.25 was used. miR-205-5p expression data were used to generate a receiver operating characteristic (ROC) curve for miR-205-5p, for which the area under the curve (AUC) was 0.825 (95{\%} confidence interval: 0.710–0.941; P = 0.001). Moreover, transfection with a miR-205-5p mimic induced cell proliferation by inhibiting the expression of the tumor suppressor protein phosphatase and tensin homolog (PTEN). Our findings suggest that miR-205-5p upregulation contributes to MDS by suppressing PTEN and that miR-205-5p thus acts as an oncogene in hematopoietic cells.",
keywords = "Diagnosis, MDS, miR-205-5p, Oncogene, Upregulation",
author = "Jang, {Sook Jin} and Choi, {In Sun} and Geon Park and Moon, {Dae Soo} and Choi, {Ji Seon} and Myung-Hyun Nam and Soo-Young Yoon and Choi, {Cheol Hee} and Kang, {Seong Ho}",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.leukres.2016.06.003",
language = "English",
volume = "47",
pages = "172--177",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression

AU - Jang, Sook Jin

AU - Choi, In Sun

AU - Park, Geon

AU - Moon, Dae Soo

AU - Choi, Ji Seon

AU - Nam, Myung-Hyun

AU - Yoon, Soo-Young

AU - Choi, Cheol Hee

AU - Kang, Seong Ho

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Micro (mi)RNA dysregulation is implicated in the development of myelodysplastic syndrome (MDS). Chromosomal abnormalities on 1q are frequently detected in Korean patients with MDS; however, how these are related to disease development is unknown. The present study compared the expression profiles of miRNAs encoded by chromosome 1q between 65 MDS patients and 11 controls. We found that miR-205-5p levels were 12.5 fold higher in the former (P = 0.001). miR-205-5p level was increased in 44.7% of patients when an arbitrary 2−ΔCt cut-off value of 1.25 was used. miR-205-5p expression data were used to generate a receiver operating characteristic (ROC) curve for miR-205-5p, for which the area under the curve (AUC) was 0.825 (95% confidence interval: 0.710–0.941; P = 0.001). Moreover, transfection with a miR-205-5p mimic induced cell proliferation by inhibiting the expression of the tumor suppressor protein phosphatase and tensin homolog (PTEN). Our findings suggest that miR-205-5p upregulation contributes to MDS by suppressing PTEN and that miR-205-5p thus acts as an oncogene in hematopoietic cells.

AB - Micro (mi)RNA dysregulation is implicated in the development of myelodysplastic syndrome (MDS). Chromosomal abnormalities on 1q are frequently detected in Korean patients with MDS; however, how these are related to disease development is unknown. The present study compared the expression profiles of miRNAs encoded by chromosome 1q between 65 MDS patients and 11 controls. We found that miR-205-5p levels were 12.5 fold higher in the former (P = 0.001). miR-205-5p level was increased in 44.7% of patients when an arbitrary 2−ΔCt cut-off value of 1.25 was used. miR-205-5p expression data were used to generate a receiver operating characteristic (ROC) curve for miR-205-5p, for which the area under the curve (AUC) was 0.825 (95% confidence interval: 0.710–0.941; P = 0.001). Moreover, transfection with a miR-205-5p mimic induced cell proliferation by inhibiting the expression of the tumor suppressor protein phosphatase and tensin homolog (PTEN). Our findings suggest that miR-205-5p upregulation contributes to MDS by suppressing PTEN and that miR-205-5p thus acts as an oncogene in hematopoietic cells.

KW - Diagnosis

KW - MDS

KW - miR-205-5p

KW - Oncogene

KW - Upregulation

UR - http://www.scopus.com/inward/record.url?scp=84978715297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978715297&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2016.06.003

DO - 10.1016/j.leukres.2016.06.003

M3 - Article

VL - 47

SP - 172

EP - 177

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

ER -